Database

Startups

Main Industry
Biotechnology
Founded Year
2017
Unified Business No.
55768097
Status
Active
Number of Employees
0
Total Paid-in Capital
1,000,000 (NT$)
Location of Company
Taiwan , Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.

Similar Companies

BIOLEGEND TAIWAN INC.

1. Antibodies and Reagents
2. Apoptosis and Cell Health Reagents
3. Buffers and Chemical Probes
4. Clinical | Analyte Specific Reagents (ASR)
5. Isotype Controls
6. Magnetic Separation - MojoSort?
7. Non-Human Primate Antibodies
8. Recombinant Proteins, Cytokines, Growth Factors
9. SARS-CoV-2 Reagents
10. Soluble MHC ? Flex?T?
11. Ultra-LEAF? | GoInVivo? Antibodies
12. Cell-Vive? GMP Portfolio

BioPro Scientific Co., Ltd.

With expertise in neuroscience research and the development of bio-electronic medicine, our team has owned the core technologies, including proprietary wireless microchips for neuromodulation, algorithms for detecting pathological brain activities, shallow brain stimulation strategies, and a smart AIoT (AI and internet-of-things) system. We are on a mission to bring our success in building a perfect method to change the diagnosis and treatment of neurological disorders and beyond.

KONTEX INC.

Our initial product offerings reflect our commitment to quality and innovation, designed to support the neuroscience research community effectively. KONTEX is also focused on expanding the application of our technologies to clinical settings, aiming to make meaningful contributions to both research and healthcare.

?

Yoda Therapeutics Inc.

Neurology
Pipeline
Utilizing Yoda’s proprietary AI-based drug screening platform, we engage in the exploration and development of promising and beneficial products to address unmet medical needs, instilling new hope in patients.YA-101 Multiple System Atrophy
YA-102 Parkinson's Disease
YA-201 Alzheimer's Disease
Neuropsychiatry
YA-301
Schizophrenia
YA-401 Autism
Cerebrovascular Disease
YA-501 Ischemic Stroke
YA-502
Traumatic Brain Injury